All News #Library
Rare Diseases
ReCode Therapeutics gets FDA Orphan Drug Designation for RCT2100
25 Mar 2025 //
BUSINESSWIRE
ReCode Receives U.S. FDA Orphan Drug Designation for RCT1100
27 Jun 2024 //
BUSINESSWIRE

Market Place
Sourcing Support